Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) COO Mukul Jain Sells 50,000 Shares

Senseonics Holdings, Inc. (NYSEAMERICAN:SENSGet Rating) COO Mukul Jain sold 50,000 shares of the business’s stock in a transaction that occurred on Thursday, August 4th. The stock was sold at an average price of $1.97, for a total value of $98,500.00. Following the sale, the chief operating officer now directly owns 2,506,156 shares in the company, valued at $4,937,127.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Senseonics Price Performance

NYSEAMERICAN SENS traded up $0.08 during trading hours on Friday, hitting $2.11. 17,436,892 shares of the company were exchanged, compared to its average volume of 8,217,378. Senseonics Holdings, Inc. has a 52 week low of $0.77 and a 52 week high of $4.28. The stock has a market capitalization of $977.48 million, a P/E ratio of -2.54 and a beta of 0.61.

Senseonics (NYSEAMERICAN:SENSGet Rating) last announced its earnings results on Tuesday, May 10th. The company reported ($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.03). The business had revenue of $2.48 million for the quarter, compared to analysts’ expectations of $2.14 million. As a group, equities research analysts anticipate that Senseonics Holdings, Inc. will post -0.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Argent Advisors Inc. purchased a new position in shares of Senseonics during the fourth quarter valued at approximately $27,000. Blackston Financial Advisory Group LLC purchased a new position in shares of Senseonics during the fourth quarter valued at approximately $27,000. Eaton Vance Management boosted its position in shares of Senseonics by 100.0% during the first quarter. Eaton Vance Management now owns 20,000 shares of the company’s stock valued at $39,000 after buying an additional 10,000 shares during the period. Falcon Wealth Planning purchased a new position in shares of Senseonics during the second quarter valued at approximately $40,000. Finally, Inspire Investing LLC purchased a new stake in shares of Senseonics in the fourth quarter valued at approximately $43,000. Hedge funds and other institutional investors own 26.81% of the company’s stock.

About Senseonics

(Get Rating)

Senseonics Holdings, Inc, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months.

Featured Articles

Insider Buying and Selling by Quarter for Senseonics (NYSEAMERICAN:SENS)

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with's FREE daily email newsletter.